annual total liabilities:
$355.33M+$186.24M(+110.15%)Summary
- As of today (June 23, 2025), TGTX annual total liabilities is $355.33 million, with the most recent change of +$186.24 million (+110.15%) on December 31, 2024.
- During the last 3 years, TGTX annual total liabilities has risen by +$212.85 million (+149.39%).
- TGTX annual total liabilities is now at all-time high.
Performance
TGTX Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$419.40M+$64.07M(+18.03%)Summary
- As of today (June 23, 2025), TGTX quarterly total liabilities is $419.40 million, with the most recent change of +$64.07 million (+18.03%) on March 1, 2025.
- Over the past year, TGTX quarterly total liabilities has increased by +$206.19 million (+96.70%).
- TGTX quarterly total liabilities is now at all-time high.
Performance
TGTX quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
TGTX Total liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +110.2% | +96.7% |
3 y3 years | +149.4% | +216.2% |
5 y5 years | +185.6% | +306.4% |
TGTX Total liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +163.2% | at high | +257.2% |
5 y | 5-year | at high | +234.3% | at high | +327.2% |
alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
TGTX Total liabilities History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $419.40M(+18.0%) |
Dec 2024 | $355.33M(+110.1%) | $355.33M(-9.8%) |
Sep 2024 | - | $393.86M(+76.1%) |
Jun 2024 | - | $223.64M(+4.9%) |
Mar 2024 | - | $213.21M(+26.1%) |
Dec 2023 | $169.09M(+25.3%) | $169.09M(+1.7%) |
Sep 2023 | - | $166.30M(-7.8%) |
Jun 2023 | - | $180.40M(+6.2%) |
Mar 2023 | - | $169.93M(+25.9%) |
Dec 2022 | $134.99M(-5.3%) | $134.99M(+15.0%) |
Sep 2022 | - | $117.41M(-4.3%) |
Jun 2022 | - | $122.63M(-7.5%) |
Mar 2022 | - | $132.64M(-6.9%) |
Dec 2021 | $142.48M(+34.0%) | $142.48M(+45.1%) |
Sep 2021 | - | $98.17M(-0.1%) |
Jun 2021 | - | $98.27M(-5.0%) |
Mar 2021 | - | $103.41M(-2.7%) |
Dec 2020 | $106.29M(-14.6%) | $106.29M(+3.0%) |
Sep 2020 | - | $103.20M(+2.8%) |
Jun 2020 | - | $100.39M(-2.7%) |
Mar 2020 | - | $103.20M(-17.0%) |
Dec 2019 | $124.40M(+108.8%) | $124.40M(+4.4%) |
Sep 2019 | - | $119.12M(+27.6%) |
Jun 2019 | - | $93.38M(-5.0%) |
Mar 2019 | - | $98.28M(+65.0%) |
Dec 2018 | $59.58M(+96.1%) | $59.58M(+39.8%) |
Sep 2018 | - | $42.63M(+8.4%) |
Jun 2018 | - | $39.34M(+10.0%) |
Mar 2018 | - | $35.76M(+17.7%) |
Dec 2017 | $30.39M(+60.7%) | $30.39M(+36.7%) |
Sep 2017 | - | $22.24M(-4.3%) |
Jun 2017 | - | $23.22M(+4.5%) |
Mar 2017 | - | $22.21M(+17.5%) |
Dec 2016 | $18.91M(+58.9%) | $18.91M(-0.1%) |
Sep 2016 | - | $18.93M(+17.6%) |
Jun 2016 | - | $16.10M(+51.6%) |
Mar 2016 | - | $10.62M(-10.8%) |
Dec 2015 | $11.90M(+79.1%) | $11.90M(+7.3%) |
Sep 2015 | - | $11.10M(+4.1%) |
Jun 2015 | - | $10.66M(-3.5%) |
Mar 2015 | - | $11.04M(+66.1%) |
Dec 2014 | $6.64M(-17.5%) | $6.64M(-36.5%) |
Sep 2014 | - | $10.46M(+148.8%) |
Jun 2014 | - | $4.21M(+12.4%) |
Mar 2014 | - | $3.74M(-53.6%) |
Dec 2013 | $8.06M(+23.5%) | $8.06M(-16.6%) |
Sep 2013 | - | $9.66M(+27.4%) |
Jun 2013 | - | $7.58M(+13.4%) |
Mar 2013 | - | $6.69M(+2.5%) |
Dec 2012 | $6.52M(+33.1%) | $6.52M(-11.1%) |
Sep 2012 | - | $7.34M(+8.8%) |
Jun 2012 | - | $6.74M(+14.6%) |
Mar 2012 | - | $5.89M(+20.1%) |
Dec 2011 | $4.90M(-79.6%) | $4.90M(-73.3%) |
Sep 2011 | - | $18.36M(-10.5%) |
Jun 2011 | - | $20.51M(+2.8%) |
Mar 2011 | - | $19.96M(-16.8%) |
Dec 2010 | $24.00M | $24.00M(-3.1%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2010 | - | $24.77M(-2.4%) |
Jun 2010 | - | $25.38M(-8.1%) |
Mar 2010 | - | $27.60M(+286.0%) |
Dec 2009 | $7.15M(+27.1%) | $7.15M(-2.4%) |
Sep 2009 | - | $7.33M(-1.6%) |
Jun 2009 | - | $7.45M(+13.4%) |
Mar 2009 | - | $6.56M(+16.7%) |
Dec 2008 | $5.62M(+200.5%) | $5.62M(+13.3%) |
Sep 2008 | - | $4.96M(+12.3%) |
Jun 2008 | - | $4.42M(+147.4%) |
Mar 2008 | - | $1.79M(-4.6%) |
Dec 2007 | $1.87M(-3.7%) | $1.87M(+4.5%) |
Sep 2007 | - | $1.79M(-29.2%) |
Jun 2007 | - | $2.53M(+15.4%) |
Mar 2007 | - | $2.19M(+12.8%) |
Dec 2006 | $1.94M(+16.7%) | $1.94M(+37.4%) |
Sep 2006 | - | $1.41M(-36.1%) |
Jun 2006 | - | $2.21M(-1.4%) |
Mar 2006 | - | $2.25M(+34.9%) |
Dec 2005 | $1.67M(+39.3%) | $1.67M(-7.9%) |
Sep 2005 | - | $1.81M(+1.9%) |
Jun 2005 | - | $1.78M(+39.7%) |
Mar 2005 | - | $1.27M(+6.3%) |
Dec 2004 | $1.20M(+23.8%) | $1.20M(-18.9%) |
Sep 2004 | - | $1.47M(+136.2%) |
Jun 2004 | - | $624.40K(-17.6%) |
Mar 2004 | - | $757.80K(-21.6%) |
Dec 2003 | $966.00K(-10.8%) | $966.00K(-23.7%) |
Sep 2003 | - | $1.27M(+20.0%) |
Jun 2003 | - | $1.05M(-0.8%) |
Mar 2003 | - | $1.06M(-1.8%) |
Dec 2002 | $1.08M(+113.0%) | $1.08M(+115.0%) |
Sep 2002 | - | $503.90K(+17.8%) |
Jun 2002 | - | $427.70K(-11.8%) |
Mar 2002 | - | $484.70K(-4.7%) |
Dec 2001 | $508.60K(-75.6%) | $508.60K(-32.0%) |
Sep 2001 | - | $748.40K(+5.9%) |
Jun 2001 | - | $706.90K(-9.3%) |
Mar 2001 | - | $779.20K(-62.5%) |
Dec 2000 | $2.08M(+246.7%) | $2.08M(+95.9%) |
Sep 2000 | - | $1.06M(+95.7%) |
Jun 2000 | - | $542.50K(+9.4%) |
Mar 2000 | - | $495.90K(-17.3%) |
Dec 1999 | $600.00K(0.0%) | $600.00K(+200.0%) |
Sep 1999 | - | $200.00K(-50.0%) |
Jun 1999 | - | $400.00K(+33.3%) |
Mar 1999 | - | $300.00K(-50.0%) |
Dec 1998 | $600.00K(+50.0%) | $600.00K(0.0%) |
Sep 1998 | - | $600.00K(0.0%) |
Jun 1998 | - | $600.00K(+200.0%) |
Mar 1998 | - | $200.00K(-50.0%) |
Dec 1997 | $400.00K(+33.3%) | $400.00K(+33.3%) |
Sep 1997 | - | $300.00K(0.0%) |
Jun 1997 | - | $300.00K(0.0%) |
Mar 1997 | - | $300.00K(0.0%) |
Dec 1996 | $300.00K | $300.00K(-25.0%) |
Sep 1996 | - | $400.00K(0.0%) |
Jun 1996 | - | $400.00K |
FAQ
- What is TG Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for TG Therapeutics?
- What is TG Therapeutics annual total liabilities year-on-year change?
- What is TG Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for TG Therapeutics?
- What is TG Therapeutics quarterly total liabilities year-on-year change?
What is TG Therapeutics annual total liabilities?
The current annual total liabilities of TGTX is $355.33M
What is the all time high annual total liabilities for TG Therapeutics?
TG Therapeutics all-time high annual total liabilities is $355.33M
What is TG Therapeutics annual total liabilities year-on-year change?
Over the past year, TGTX annual total liabilities has changed by +$186.24M (+110.15%)
What is TG Therapeutics quarterly total liabilities?
The current quarterly total liabilities of TGTX is $419.40M
What is the all time high quarterly total liabilities for TG Therapeutics?
TG Therapeutics all-time high quarterly total liabilities is $419.40M
What is TG Therapeutics quarterly total liabilities year-on-year change?
Over the past year, TGTX quarterly total liabilities has changed by +$206.19M (+96.70%)